The Need for and Design of Combination Vaccines

  • 2 Citations


Combination vaccines, by increasing the number of antigens that can be delivered at a single visit, will dramatically extend the range of diseases preventable by childhood immunization. As the antigenic possibilities and researchers’ technical capabilities increase, the rational design and development of combination vaccines become especially complex. A variety of epidemiological, medical, physicochemical, and commercial considerations are taken into account by manufacturers in determining which set(s) of antigens make “sense “ as combinations. A key challenge will be to predict and/or influence which antigens will be recommended for inclusion in the infant schedules in key markets in the coming years. Resource constraints dictate that companies must minimize the numbers of combinations to be developed, while at the same time offer combinations appropriate to different markets around the globe.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 189

This is the net price. Taxes to be calculated in checkout.


  1. 1.

    Baker PJ, ed. The Jordan Report: Accelerated development of vaccines, 1996. Bethesda, MD: U.S. National Institute of Allergy and Infectious Diseases, National Institutes of Health; 1996.

  2. 2.

    Hausdorff WP, Paradiso PR. International Experience with IPV and OPV: Lessons for the U.S. Abstract #119, Presented at 31st Annual National Immunization Conference, Detroit, MI, May 19–22, 1997.

  3. 3.

    Dobson S, Scheifele D, Bell A. Assessment of a universal, school-based hepatitis B vaccination program. JAMA. 1995;274(15):1242–1243.

  4. 4.

    Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. Infect Dis. 1995; 171:885–889.

  5. 5.

    Rossi A, Ruvinski R, Regueira M, Corso A, Pace J, Gentile A, DiFabio JL, the Streptococcus pneumoniae Working Group. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Microbial Drug Resist. 1997;3(2):135–140.

  6. 6.

    Nielsen SV, Henrichsen J. Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989-94. Epidemiol Infect. 1996;117:411–416.

Download references

Author information

Correspondence to Dr. William P. Hausdorff PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hausdorff, W.P. The Need for and Design of Combination Vaccines. Ther Innov Regul Sci 32, 13–17 (1998) doi:10.1177/009286159803200103

Download citation

Key Words

  • Combination vaccines
  • Pediatric immunization
  • Vaccine strategy